The majority of the mutations were described in glycyl-tRNA synthetase (GARS, MIM#600287) causing CMT2 type D (CMT2D) or distal spinal muscular atrophy type V (dSMA-V), both are autosomal dominant upper limb predominant motor axonal neuropathies. Here, GARS1 is linked to Motor axonal neuropathy.